Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated With Favorable Outcomes In Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial (Alliance)
- Citation:
- Blood vol 144 (Supplement 1) 224
- Meeting Instance:
- ASH 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None